KARS mutations, which could activate the RAS-RAF-MEK-ERK signaling pathway and stimulate cell proliferation (7), were found in most colorectal cancer cases (18) and were typically enriched in patients with bigger tumors than those in our study. This evidence concerns the gene KARS1 and colorectal cancer.